Drugs / NN1218
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01121289 | Apr → Jul 2010 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NN1218 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01121289 ↗ |
| Route | Subcutaneous | “injected subcutaneously (under the skin)” NCT01121289 ↗ |